Past Issues

  1. Home
  2. Past Issues

SSRI - Paxil etc)

"Paxil" antidepressant tablets (manufactured and distributed by GlaxoSmithKline K.K.) are a type of SSRI (selective serotonin reuptake inhibitor) which came out on the market in November 2000 in Japan.
It is now widely used as an antidepressant, and was the top-earning antidepressant in the Japanese market (50 billion yen) in 2007.

Our activities are as follows:

Submission of written requests to the Ministry of Health, Labour and Welfare and companies, asking to disclose information of suicide risk concerning SSRI

Held a symposium (speaker: Charles Medawar)

Held a symposium (speaker: David Healy)

Submission of request letters regarding violence issues to,
the companies (request revisions of the package insert),
the Ministry of Justice (request a survey),
the Ministry of Health, Labour and Welfare (request a survey),
the Japan Federation of Bar Associations (request a survey)

Submission of an open question "Demand for Publication of Information Related to Post-Marketing Clinical Trials on Children and Adolescents Using the Antidepressant Paxil" to GSK and the Ministry of Health, Labour and Welfare (the MHLW).

Based on the above observations, we have strong doubts over the legitimacy of conducting this pediatric study, and submit a request letter entitled "Revision of Package Insert and Need of information leaflet or Patient on Antidepressant Paxil Tablets in Pregnant Women" to GSK and the MHLW.

Held a symposium (speaker: David Healy, Derelie Mangin)

Table Of Contents